医疗体制弊端与药品定价扭曲

通过对中国医疗体制和药价管制模式的分析，我们发现公立医疗机构在药品零售环节上的双向垄断地位是导致药价虚高的根本原因，医疗服务价格低估导致的“以药补医”机制赋予了医疗机构抬高药价的合法权力，而收益率管制政策进一步诱导医院进销高价药品。此外，单独定价政策加之宽松的新药审批制度为药厂提高药价、医院购销高价药提供了便利。所有这些问题的出现根源于政府管制措施的失当。因此，解决药价虚高的根本措施是减少政府管制，放开处方药零售权，改革公费医疗和医疗保险报销制度，打破公立医院垄断。

Defects in the medical system and distortion in drug pricing

Through an analysis of China's healthcare system and the regulatory model of pharmaceutical pricing, the paper concludes that the prime cause of pharmaceutical pricing inflation is the two- directional monopoly of public healthcare institutions on pharmaceutical retailing.The low cost of medical services means that public hospitals can legitimately use the sale of pharmaceuticals to subsidize the provision of services.Moreover, the policy of controlling the rate of return gives public hospitals a further in...